Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
INSY [NASD]
INSYS Therapeutics, Inc.
Index- P/E37.20 EPS (ttm)1.14 Insider Own0.50% Shs Outstand34.20M Perf Week15.40%
Market Cap1.45B Forward P/E19.75 EPS next Y2.15 Insider Trans-10.00% Shs Float33.93M Perf Month-6.54%
Income40.40M PEG1.55 EPS next Q0.28 Inst Own22.40% Short Float6.14% Perf Quarter11.61%
Sales99.30M P/S14.61 EPS this Y181.00% Inst Trans0.04% Short Ratio4.68 Perf Half Y76.63%
Book/sh2.44 P/B17.38 EPS next Y70.67% ROA67.80% Target Price62.00 Perf Year389.16%
Cash/sh1.33 P/C31.95 EPS next 5Y24.00% ROE165.00% 52W Range6.20 - 57.91 Perf YTD64.32%
Dividend- P/FCF75.54 EPS past 5Y16.10% ROI52.10% 52W High-26.77% Beta1.52
Dividend %- Quick Ratio3.20 Sales past 5Y- Gross Margin87.20% 52W Low584.35% ATR3.09
Employees202 Current Ratio3.90 Sales Q/Q243.60% Oper. Margin32.80% RSI (14)54.71 Volatility6.66% 8.58%
OptionableYes Debt/Eq0.00 EPS Q/Q145.60% Profit Margin40.60% Rel Volume0.74 Prev Close42.41
ShortableYes LT Debt/Eq0.00 EarningsNov 12 BMO Payout0.00% Avg Volume445.35K Price42.41
Recom1.30 SMA207.69% SMA50-0.61% SMA20045.95% Volume0 Change0.00%
14-Aug-13Reiterated Oppenheimer Outperform $23 → $27
31-Jul-13Initiated Oppenheimer Outperform $23
22-Apr-14 04:30PM  Insys Therapeutics to Present at 39th Annual Deutsche Bank Health Care Conference Marketwired +5.94%
03-Apr-14 01:47PM  Nasdaq stocks posting largest percentage decreases AP
02-Apr-14 06:16PM  Nasdaq stocks posting largest percentage decreases AP -6.57%
07:00AM  New Haven Pharmaceuticals Appoints Larry Dillaha, M.D. as Executive Vice President Operations PR Newswire
01-Apr-14 05:19PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi EDGAR Online
10:00AM  Insys Therapeutics, Inc. [INSY] to Ring The NASDAQ Stock Market Opening Bell GlobeNewswire
31-Mar-14 09:00AM  Stock Futures Look Favorable; Legg Mason, Novartis, Climb at Investor's Business Daily
07:03AM  Splits Calendar: Insys Therapeutics splits before market open today (3:2 ratio) Briefing.com
07:00AM  Insys Therapeutics Completes Three-for-Two Stock Split Through Stock Dividend Marketwired
28-Mar-14 06:00AM  'Mad Money' Lightning Round: Marathon Petroleum's For Me at TheStreet -8.69%
19-Mar-14 04:30PM  Insys Therapeutics to Present at the 13th Annual Needham Healthcare Conference Marketwired
18-Mar-14 10:55AM  Insys Therapeutics (INSY) Showing Signs Of A Dead Cat Bounce Today at TheStreet +6.36%
09:02AM  Galena: A Good Investment Gone Bad at Seeking Alpha
17-Mar-14 02:32PM  Should You Believe Tesaro's Hype? at Motley Fool -5.26%
14-Mar-14 11:45AM  Insider Trading Alert - INSY, RAI And ACGL Traded By Insiders at TheStreet
11-Mar-14 01:04PM  INSYS THERAPEUTICS, INC. Financials EDGAR Online Financials
07-Mar-14 06:16PM  Is Galena Following In The Footsteps Of Insys With Abstral? at Seeking Alpha
06:16PM  Is Galena Following In The Footsteps Of Insys With Abstral?
05-Mar-14 06:32PM  Has Insys Run Too Far Too Fast? at Motley Fool -8.94%
06:32PM  Has Insys Run Too Far Too Fast?
06:02AM  INSYS THERAPEUTICS, INC. Files SEC form 10-K, Annual Report EDGAR Online
12:43AM  INSYS Therapeutics (INSY) Soars: Stock Adds 21.7% in Session Zacks
12:43AM  INSYS Therapeutics (INSY) Soars: Stock Adds 21.7% in Session
04-Mar-14 07:53PM  Insys Therapeutics: Today's Big Biotech Winner at Motley Fool +21.73%
07:53PM  Insys Therapeutics: Today's Big Biotech Winner
03:44PM  Insys Q4 Earnings Beat Street; Stock Hits High Optionetics
03:44PM  Insys Q4 Earnings Beat Street; Stock Hits High at Investor's Business Daily
03:44PM  Insys Q4 Earnings Beat Street; Stock Hits High
03:09PM  Stocks Rally As Ukraine Fears Ebb; China Names Lead Optionetics
03:09PM  Stocks Rally As Ukraine Fears Ebb; China Names Lead at Investor's Business Daily
03:09PM  Stocks Rally As Ukraine Fears Ebb; China Names Lead
01:23PM  Why Insys Therapeutics, Inc. Shares Skyrocketed at Motley Fool
01:23PM  Why Insys Therapeutics, Inc. Shares Skyrocketed
09:31AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial S EDGAR Online
08:30AM  Wall Street recovers as Ukraine drama plays out at CNBC
06:54AM  Insys Therapeutics announces three-for-two stock split at theflyonthewall.com
06:50AM  Insys Therapeutics Reports Fourth Quarter and Year End 2013 Results Marketwired
01-Mar-14 08:32AM  Insys Set To Report Q4 Earnings With Stock Surging at Investor's Business Daily
28-Feb-14 05:55PM  With economy on ice, bulls push for more new highs at CNBC
21-Feb-14 07:01AM  Insys Therapeutics reports dismissal of stockholder class action lawsuit theflyonthewall.com
07:00AM  Insys Therapeutics Reports Dismissal of Stockholder Class Action Lawsuit Marketwired
18-Feb-14 11:27AM  Commit To Purchase Insys Therapeutics At $45, Earn 25.4% Annualized Using Options at TheStreet +7.26%
12-Feb-14 04:30PM  Insys Therapeutics to Report Fourth Quarter and Year-End 2013 Financial Results on March 4 Marketwired
01:24PM  Insys Recovers From Stock Hit Tied To Fed Probe at Investor's Business Daily
02-Feb-14 01:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Insys Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline -- INSY GlobeNewswire
01:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Insys Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline -- INSY
31-Jan-14 09:20PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in Insys Therapeutics, Inc. to Contact Brower Piven Before the February 14, 2014 Lead Plaintiff Deadline Business Wire
09:20PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in Insys Therapeutics, Inc. to Contact Brower Piven Before the February 14, 2014 Lead Plaintiff Deadline
24-Jan-14 11:19AM  A Comprehensive Look At Galena at Seeking Alpha
17-Jan-14 02:17PM  SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Insys Therapeutics, Inc. and Certain Officers -- INSY PR Newswire +7.20%
02:17PM  SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Insys Therapeutics, Inc. and Certain Officers -- INSY
13-Jan-14 07:00AM  Insys Announces Details of Product Development Pipeline Marketwired
07:00AM  Insys Announces Details of Product Development Pipeline Marketwire
07:00AM  Insys Announces Details of Product Development Pipeline
11-Jan-14 04:26PM  EQUITY ALERT: Rosen Law Firm Announces Class Action Lawsuit Against Insys Therapeutics, Inc. -- INSY GlobeNewswire
04:26PM  EQUITY ALERT: Rosen Law Firm Announces Class Action Lawsuit Against Insys Therapeutics, Inc. -- INSY
06-Jan-14 06:14PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in Insys Therapeutics, Inc. to Contact Brower Piven Before the February 14, 2014 Lead Plaintiff Deadline Business Wire
06:14PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in Insys Therapeutics, Inc. to Contact Brower Piven Before the February 14, 2014 Lead Plaintiff Deadline
05:18PM  Insys Therapeutics to Present at the 32nd Annual J.P. Morgan Healthcare Conference Marketwired
05:18PM  Insys Therapeutics to Present at the 32nd Annual J.P. Morgan Healthcare Conference Marketwire
05:18PM  Insys Therapeutics to Present at the 32nd Annual J.P. Morgan Healthcare Conference
03-Jan-14 02:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Insys Therapeutics, Inc. of Class Action Law Suit and Upcoming Deadline -- INSY GlobeNewswire
02:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Insys Therapeutics, Inc. of Class Action Law Suit and Upcoming Deadline -- INSY
02-Jan-14 11:34AM  Top Trial Firm Cohen, Placitella & Roth, PC Investigating Insys Therapeutics, Inc., for Potential Violations of Securities Laws Involving Health and Human Services Programs PR Newswire
11:34AM  Top Trial Firm Cohen, Placitella & Roth, PC Investigating Insys Therapeutics, Inc., for Potential Violations of Securities Laws Involving Health and Human Services Programs
31-Dec-13 03:40PM  SMA Gains on Debt Reduction Plans Zacks
03:40PM  SMA Gains on Debt Reduction Plans
09:55AM  [video] 2013 IPO scorecard: 4 big winners at CNBC
09:55AM  [video] 2013 IPO scorecard: 4 big winners
29-Dec-13 09:18AM  Insys Therapeutics Inc: The Best Performing Biotechs of 2013 at Motley Fool
09:18AM  Insys Therapeutics Inc: The Best Performing Biotechs of 2013
27-Dec-13 05:00PM  [video] Best IPO of 2013: Insys Therapeutics at CNBC
05:00PM  [video] Best IPO of 2013: Insys Therapeutics
03:12PM  [video] Will tech IPO's thrive in 2014? at CNBC
03:12PM  [video] Will tech IPO's thrive in 2014?
20-Dec-13 10:51AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financi EDGAR Online
10:51AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financi
10:11AM  The IPO Class Of 2014: After Twitter, Alibaba On Center Stage at Forbes
19-Dec-13 04:47PM  Tech IPOs Among Top Performers As 2013 Winds Down at Investor's Business Daily
04:47PM  Tech IPOs Among Top Performers As 2013 Comes To Close at Investor's Business Daily
18-Dec-13 06:50PM  Morgan & Morgan Announces That a Class Action Was Filed Against Insys Therapeutics, Inc. -- INSY GlobeNewswire
04:57PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses From Investment in Insys Therapeutics, Inc. to Contact Brower Piven Before the February 14, 2014 Lead Plaintiff Deadline -- INSY GlobeNewswire
17-Dec-13 05:27PM  INVESTOR ALERT: Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit Against Insys Therapeutics, Inc. (NASDAQ: INSY) Marketwired
03:18PM  Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Insys Therapeutics, Inc. PR Newswire
16-Dec-13 05:41PM  Pomerantz Law Firm Has Filed a Class Action Against Insys Therapeutics, Inc. and Certain Officers -- INSY GlobeNewswire +5.91%
10:04AM  Insys Therapeutics (INSY) Is Today's Dead Cat Bounce Stock at TheStreet
14-Dec-13 08:29AM  The Best- And Worst-Performing Biotech Stocks, Dec. 6 to Dec. 13 at Forbes
13-Dec-13 08:18PM  Shareholder Alert -- Girard Gibbs LLP Investigates Potential Securities Claims on Behalf of Investors of INSYS Therapeutics, Inc. (INSY) Business Wire -15.63%
07:00PM  Harwood Feffer LLP Announces Investigation of INSYS Therapeutics, Inc. PR Newswire
06:35PM  EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Fraud Claims Against INSYS Therapeutics, Inc. --- INSY Business Wire
04:44PM  SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Insys Therapeutics, Inc. - INSY PR Newswire
03:46PM  Buzz on the Street: Naughty Bears May Keep Santa Away at Minyanville
01:54PM  Why Insys Therapeutics Inc. Shares Plunged at Motley Fool
12:18PM  Investor Alert: Holzer & Holzer, LLC Announces Investigation into Insys Therapeutics, Inc. Business Wire
10:27AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of INSYS Therapeutics, Inc. - INSY PR Newswire
10:26AM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of INSYS Therapeutics, Inc. PR Newswire
09:15AM  Keep a Close Watch on Insys and XOMA Today at Motley Fool
07:29AM  Story Stocks from Briefing.com Briefing.com
06:01AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
12-Dec-13 09:32PM  Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of Insys Therapeutics, Inc. Business Wire
Insys Therapeutics, Inc., a commercial-stage specialty pharmaceutical company, develops and commercializes supportive care products. It focuses on utilizing its proprietary formulation technologies to address the clinical shortcomings of existing commercial pharmaceutical products. The company markets Subsys, a proprietary sublingual fentanyl spray for breakthrough pain in opioid-tolerant cancer patients; and Dronabinol Oral Solution, a proprietary orally administered liquid formulation of dronabinol. It offers its Subsys through its incentive-based commercial sales force. The company also provides Dronabinol SG Capsule, a generic equivalent to Marinol (dronabinol), an approved second-line treatment for chemotherapy-induced nausea and vomiting, and anorexia associated with weight loss in patients with AIDS. Insys Therapeutics, Inc. was incorporated in 1990 and is headquartered in Chandler, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Babich Michael LPresident and CEOMar 18Option Exercise2.9590,000265,72895,375Mar 18 06:54 PM
STANLEY THEODORE HDirectorMar 13Buy71.9530021,5851,400Mar 13 04:18 PM
STANLEY THEODORE HDirectorMar 12Buy73.4020014,6801,100Mar 13 04:18 PM
STANLEY THEODORE HDirectorMar 06Buy74.2620014,853900Mar 06 07:05 PM
Babich Michael LPresident and CEOMar 05Option Exercise1.84212,125390,184293,807Mar 06 07:02 PM
Dillaha LarryChief Medical OfficerMar 05Option Exercise3.18149,932476,836153,057Mar 06 07:03 PM
STANLEY THEODORE HDirectorMar 05Buy77.2920015,459700Mar 06 07:05 PM
Babich Michael LPresident and CEOMar 05Sale74.58288,43221,512,1125,375Mar 06 07:02 PM
Dillaha LarryChief Medical OfficerMar 05Sale74.57149,93211,179,7623,125Mar 06 07:03 PM